April 26th 2024
Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.
Read More
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
Model for predicting cesarean delivery in gestational diabetes
November 15th 2023A recent study unveils a pragmatic model, incorporating factors such as insulin requirements, preeclampsia, and maternal age, to effectively predict primary cesarean delivery risk in pregnancies complicated by gestational diabetes mellitus.
Read More
Hematocrit levels in newborns: EPP vs. DCC study reveals surprising findings
November 7th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Read More
Reducing postpartum length of stay following vaginal or cesarean delivery
September 13th 2023A targeted, collaborative approach to reduce length of stay (LOS) after cesarean or vaginal delivery resulted in a significant and sustained decrease in mean postpartum LOS without compromising patient safety, according to a poster featured at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting, held in Chicago, Illinois.
Read More
FDA approves Pfizer’s maternal vaccine to prevent RSV in infants
August 22nd 2023Approved for use at 32 weeks through 36 weeks gestation, Pfizer’s maternal respiratory syncytial vaccine (Abrysvo), is delivered through a single dose injection to the muscle, and is the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD because of RSV in infants (birth to 6 months).
Read More